News

May 15, 2026

Q1 2026 Results Presentation

more

May 06, 2026

Designing Ligands for GID4 Ligase

more

April 28, 2026

Investors Meeting

more

February 11, 2026

Captor reports: Targeted degradation of GSPT1 in preclinical models of high-risk neuroblastoma

more

November 28, 2025

NEK7 Kinase: A Breakthrough Target in Inflammation Therapy – Investing in Next-Generation Medicine

more

November 19, 2025

Captor Therapeutics and MD Anderson Cancer Center Sign Research Collaboration Agreement

more

November 19, 2025

Captor Therapeutics Enters into a Strategic Agreement with a Pharmaceutical Partner

more

November 13, 2025

CT-05 The Power of an Antibody in a Tablet

more